# Effectiveness of Lung Impedance Guided Preemptive Therapy of Chronic Heart Failure Patients With Preserved Ejection Fraction (LVEF ≥ 45%) in Our Hospital's Outpatient Clinic

> **NCT02661841** · NA · UNKNOWN · sponsor: **Hillel Yaffe Medical Center** · enrollment: 300 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** LI-Guided Therapy
- **OTHER:** Heart Failure Guidelines

## Key facts

- **NCT ID:** NCT02661841
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02-01
- **Primary completion:** 2022-01
- **Final completion:** 2022-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02661841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02661841, "Effectiveness of Lung Impedance Guided Preemptive Therapy of Chronic Heart Failure Patients With Preserved Ejection Fraction (LVEF ≥ 45%) in Our Hospital's Outpatient Clinic". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02661841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*